Lymphatic Filariasis Elimination Program updates, Nepal

2

Lymphatic Filariasis Elimination Program updates, Nepal

Lymphatic Filariasis Burden in Nepal

    • Endemic districts: 61
    • Average prevalence: 13%
    • Population at risk: 25 million
    • Causative agent: Wuchereria bancrofti
    • Transmission vector : Culex quinquefasciatus
    • Reported chronic conditions : > 30,000; majority are hydrocele

DOWNLOAD MATERIALS FOR MDA PLANNING 2019

Lymphatic Filariasis Elimination Program, Nepal

Goal

  • To eliminate LF as a public health problem by 2020

Target

  • To cover with MDA all LF endemic districts by 2014 and achieve <1% prevalence in all endemic districts by 2020

Strategy

  • Interruption of transmission by MDA – Diethylcarbamazine (DEC) and Albendazole, yearly campaign for six years
  • Morbidity management & Disability Prevention

LF Elimination Strategies & Steps

  • Interruption of transmission by Mass Drug Administration (MDA) using two drugs regimen, Diethylcarbamazine (DEC) and Albendazole, once yearly for six years.
  • Morbidity Management by self care and with support using intensive but simple, effective and local hygiene technique.

Monitoring and Evaluation During and After MDA

  • Coverage is monitored at each MDA round to determine whether the goal of at least 65% coverage of the total population was met.
  • After at least five rounds of effective MDA, the impact is evaluated at sentinel and spot-check sites.
  • If all the eligibility criteria are met, a transmission assessment survey (TAS) is conducted before deciding to stop MDA.
  • TAS is repeated twice during post-MDA surveillance phase.

Progress Towards LF Elimination: As of Dec 2018

  • Mapping done: 2001,2005/2006, 2012
  • Geographical Coverage: MDA started from 1 district in 2003 & Reached 100% in 2013,
  • MDA stopped in 46 districts after TAS 1
  • 2 districts are scheduled for TAS 1 in 2019
  • TAS 2 succeeded in14 districts & TAS 3 succeeded in 5 districts
  • Almost 110 million doses of MDA drugs administered.
  • Post MDA surveillance and morbidity management ongoing.
  • 12 districts completed MMDP mapping using Measure SMS Reporting and expanding rapidly.

Morbidity Management and Disability Prevention (MMDP) Status – 2018

  • Free Hydrocele Surgery done – 7327 cases (Till 2018) and free surgeries ongoing in all endemic districts.
  • Morbidity mapping completed in 12 districts and 9 more in plan for 2019 (9511 Cases)
  • Successful Integration with LF and leprosy self care in 1 (Lalgadh) Hospital & in talk with few others.

Source of Info: EDCD Presentation 



DOWNLOAD MATERIALS FOR MDA PLANNING 2019


Egypt eliminates lymphatic filariasis
Diseases Control Program in Nepal : Lymphatic Filariasis
Descriptive Epidemiology of Scrub Typhus in Nepal, 2017
Bye – Bye 👋👋👋 Trachoma 👁‍🗨👁‍🗨 from Nepal 🇳🇵
Classification of Water-related diseases
Malaria Micro Stratification Report 2018

Read also:  Prevention of Scrub Typhus
Share.

About Author

Sagun's Blog is popular health information sharing online platform initiated by Sagun Paudel since 2011. Thousands of health professionals have trusted Sagun’s Blog as a right website to find the latest public health opportunities, information & resources for health updates in Nepal. Sagun’s Blog is also serving information on global opportunities for international visitors. The main purpose of this blog is to share the right public health updates, information & opportunities in right time for public health professionals. The most popular information in this blog are jobs, scholarships, conferences, fellowships, awards, internships, grants, national & international plan policy, guideline, report, and health news. Sagun’s Blog is committed & dedicated to delivering accurately, trusted, up-to-date health information & opportunities to all health professionals. This initiation will help every public health professionals to have access to the right information & opportunities at right time to develop their professional career.

Loading...